Related research shows blood or urine sample can be used
UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of American Association for the Study of Liver Disease (AASLD) in San Francisco, Nov. 14-16. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.
“Our novel HCV antigen test system has significantly improved sensitivity and specificity over current tests. Importantly, for the first time, we can use urine specimens for one-step screening and diagnosing of HCV infection,” said Hu, professor of gastroenterology and hepatology at UC Irvine School of Medicine. “Finding a more convenient, easy-to-use and cost-effective screening alternative is imperative, because HCV is significantly under-screened and under-diagnosed.”
Although the current HCV screening test is specific and sensitive, it cannot distinguish active infection from a previous infection. A blood sample is required, and two steps are required. First, virus-specific antibodies must be detected in the blood. Then, the sensitive HCV RNA PCR test must be administered to confirm whether or not the infection is active. Hu said many developing countries are not equipped to administer the two-step test, especially the HCV RNA PCR test. In the U.S., its cost is above $200. The novel HCV antigen test system developed by Hu’s UC Irvine lab could significantly reduce the cost, human resources and time required for the test results.
“The ability to detect infection using urine rather than blood avoids needle stick and blood sample collection, greatly reduces the cost and necessary clinical infrastructure for screening and diagnosis, helping to promote widespread adoption of the test on a global scale,” Hu said.
According to the Centers for Disease Control and Prevention, approximately 150 million people worldwide and 3.2 million people in the U.S. are infected with HCV. Effective screening and fast diagnosis are critical for treatment and controlling transmission.
“Those who are HCV infected can now be cured, before a further liver injury and complications develop, but only if they are diagnosed” Hu said.
Read more: One-step test for hepatitis C virus infection developed by UC Irvine Health researchers
The Latest on: Hepatitis C
[google_news title=”” keyword=”hepatitis C” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hepatitis C
- Hepatitis C diagnosis 'like a death sentence'on April 27, 2024 at 12:46 am
A woman who contracted hepatitis C after being given contaminated blood during a transfusion more than 50 years ago says she feels like her life "has been stolen". Hazel Busby, 73, says the ordeal ...
- Canada Will Likely Miss WHO's Hepatitis C Elimination Targeton April 25, 2024 at 3:35 am
Canada is unlikely to meet the World Health Organization's (WHO's) target of eliminating the hepatitis C virus ( HCV) by 2030, research suggested. The elimination targets for HCV include an 80% ...
- Recovery and treatment service marks 'micro-elimination' of potentially deadly hepatitis C in countyon April 24, 2024 at 9:59 pm
A Shropshire based service says it has achieved the "micro-elimination" of the blood-borne infection hepatitis C in the county.
- Hepatitis Kills 3500 People Each Day, Says WHOon April 24, 2024 at 7:28 pm
Although annual incidence decreased from 2.5 million in 2019 to 2.2 million in 2022, the WHO considers it to be high.
- Global Hepatitis C Virus (HCV) Testing Industryon April 22, 2024 at 12:13 pm
The Global Hepatitis C Virus (HCV) Testing Industry is on a promising growth trajectory, fueled by increasing awareness and improved diagnostic tools. According to industry estimates, the market ...
- Ontario to miss Canada’s WHO target to eliminate hepatitis C as a public-health threat by 2030on April 19, 2024 at 1:21 pm
University of Waterloo professor says harm reduction strategies are necessary to achieve the target for new cases ...
- World Liver Day: Prioritizing Viral Hepatitis Screening With Comprehensive Testingon April 18, 2024 at 11:05 pm
The primary reason to screen for Hepatitis B and C infection is to reduce morbidity and mortality associated with chronic liver disease and to curtail transmission.
- Canada's Hepatitis C Elimination Target Likely Out of Reachon April 17, 2024 at 11:36 am
Sole focus on screening and treatment may hinder experts from meeting the WHO's 2030 goal to eliminate hepatitis C virus (HCV).
- Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t trackedon April 17, 2024 at 1:30 am
Before Covid emerged, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined.
- WHO Sounds Alarm on Viral Hepatitis Infections Claiming 3,500 Lives Each Dayon April 16, 2024 at 2:02 am
Report shows only 3% of people with hepatitis B and 20% of those with hepatitis C have received antiviral treatment.
via Bing News